Stryker Enters China Race With Trauson Bid

The race to acquire a local foothold in China’s medical device industry is on. Stryker's bid to pay $764 million for Trauson Holdings would take out China’s second sizable domestic supplier of orthopedic implants.

More from Global Vision

More from In Vivo